ADORA BOSAH: Open Payments
NPI 1386109346 · WHITE PLAINS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,866 in 80 payments from 12 companies in 2025. Trend: 2023 $1,093 · 2024 $1,447 · 2025 $1,866
Food & beverage: $1,851Education: $15
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 13 | $402 |
| Lundbeck LLC | 11 | $236 |
| Neurocrine BioSciences, Inc. | 8 | $228 |
| Alkermes, Inc. | 13 | $212 |
| Teva Pharmaceuticals USA, Inc. | 9 | $182 |
| E.R. Squibb & Sons, L.L.C. | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Axsome Therapeutics, Inc. | 4 | $93 |
| Janssen Pharmaceuticals, Inc | 2 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
Products named: INGREZZA, FANAPT, HETLIOZ, REXULTI, ARISTADA, UZEDY, COBENFY, ABILIFY ASIMTUFII.
Industry payments across MD — which companies pay providers there.
